Do Price Subsidies on Artemisinin Combination Therapy for Malaria Increase Household Use?: Evidence from a Repeated Cross-Sectional Study in Remote Regions of Tanzania

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Cohen, Jessica L ^a,b   Yadav, Prashant ^c   Moucheraud, Corrina ^a   Alphs, Sarah ^c   Larson, Peter S ^c   Arkedis, Jean ^d   Massaga, Julius ^e   Sabot, Oliver ^f  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BROOKINGS INSTITUTION   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d RESULTS FOR DEVELOPMENT INSTITUTE   (United States)

^e NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (Tanzania)

^f Slingshot Publications   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CROSS-SECTIONAL STUDY; DRUG BIOAVAILABILITY; DRUG COST; DRUG EFFICACY; GEOGRAPHIC DISTRIBUTION; HEALTH CARE ACCESS; HEALTH SURVEY; HELP SEEKING BEHAVIOR; HOUSEHOLD; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALARIA; MEDICAL INFORMATION; PRESCHOOL CHILD; PUBLIC HEALTH PROBLEM; SCHOOL CHILD; SEASONAL VARIATION; TANZANIA;

ANTIMALARIALS; ARTEMISININS; CROSS-SECTIONAL STUDIES; DRUG THERAPY, COMBINATION; GEOGRAPHY; HEALTH SERVICES ACCESSIBILITY; HUMANS; MALARIA; TANZANIA;

EID: 84880800508     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0070713     Document Type: Article

References (41)

1. World Health Organization (2010) Guidelines for the Treatment of Malaria. Geneva, Switzerland: World Health Organization.
2. Bhattarai A, Ali AS, Kachur SP, Märtensson A, Abbas AK, et al. (2007) Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Medicine 4(11): e309.
3. Otten M, Aregawi M, Were W, Karema C, Medin A, et al. (2009) Initial evidence of reduction of malaria cases and deaths in Rwanda and Ethiopia due to rapid scale-up of malaria prevention and treatment. Malaria Journal 8: 14.
4. O'Connell KA, Gatakaa H, Poyer S, Njogu J, Evance I, et al. (2011) Got ACTs?: Availability, price, market share and provider knowledge of anti-malarial medicines in public and private sector outlets in six malaria-endemic countries. Malaria Journal 10: 326.
5. Patoillard E, Hanson KG, Goodman CA, (2010) Retail sector distribution chains for malaria treatment in the developing world: a review of the literature. Malaria Journal 9: 50.
6. Talisuna A, Grewal P, Rwakimari JB, Mukasa S, Jagoe G, et al. (2009) Cost is killing patients: subsidizing effective antimalarials. The Lancet 374(9697): 1224-1226.
7. Kangwana BB, Njogu J, Wasunna B, Kedenge SV, Memusi DN, et al. (2009) Malaria drug shortages in Kenya: a major failure to provide access to effective treatment. American Journal of Tropical Medicine and Hygiene 80(5): 737-738.
8. Zurovac D, Ndhlovu M, Sipilanyambe N, Sipilanyambe N, Chanda P, et al. (2007) Pediatric malaria case-management with artemether-lumefantrine in Zambia: a repeat cross-sectional study. Malaria Journal 6: 31.
9. Zurovac D, Tibenderana JK, Nankabirwa J, Ssekitooleko J, Njogu JN, et al. (2008) Malaria case-management under artemether-lumefantrine treatment policy in Uganda. Malaria Journal 7: 181.
10. Sudoi RK, Githinji S, Nyandigisi A, Muturi A, Snow RW, et al. (2012) The magnitude and trend of artemether-lumefantrine stock-outs at public health facilities in Kenya. Malaria Journal 11: 37.
11. Onwujekwe O, Hanson K, Uzochukwu B, Ezeoke O, Eze S, et al. (2010) Geographic inequities in provision and utilization of malaria treatment services in southeast Nigeria: Diagnosis, providers and drugs. Health Policy 94(2): 144-149.
12. Cohen JM, Sabot O, Sabot K, Gordon M, Gross I, et al. (2010) A pharmacy too far? Equity and spatial distribution of outcomes in the delivery of subsidized artemisinin-based combination therapies through private drug shops. BMC Health Services Research 10(Suppl 1): S6.
13. The Global Fund to Fight AIDS, Tuberculosis and Malaria (2010) Global Fund quality assurance policy for pharmaceutical products. Twenty-second Board Meeting, Sofia, 13-15 Dec 2010. GF-B22-11, Revision 1, Annex 1.
14. Adeyi O, Atun R, (2010) Universal access to malaria medicines: innovation in financing and delivery. The Lancet 376(9755): 1869-1871.
15. Laxminarayan R, Gelband H, (2009) A Global Subsidy: Key to Affordable Drugs for Malaria? Health Affairs 28(4): 949-961.
16. World Health Organization (2011) World Malaria Report. Geneva, Switzerland: World Health Organization.
17. Arrow K, Panosian C, Gelband H, editors. (2004) Saving Lives, Buying Time: Economics of Malaria Drugs in an Age of Resistance. Washington D.C.: Institute of Medicine, National Academies Press.
18. AMFm Independent Evaluation Team (ICF International and London School of Hygiene and Tropical Medicine) (2012) Independent Evaluation of Phase 1 of the Affordable Medicines Facility-malaria (AMFm). Available: http://www.theglobalfund.org/en/amfm/independentevaluation/. Accessed 2013 Jul 2.
19. Tougher S, Yazoume Y, Amuasi JH, Kourgueni IA, Thomson R, et al. (2012) Effect of the Affordable Medicines Facility-malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data. The Lancet 380(9857): 1916-1926.
20. Kamal-Yanni M, (2010) Affordable Medicines Facility for malaria: reasonable or rash? The Lancet 375(9709): 121.
21. Bitran R, Martorell B. (2009) AMFm: Reaching the poorest of the poor with effective malaria drugs. Resources for the Future Discussion Paper. Available: http://www.rff.org/Publications/Pages/PublicationDetails.aspx?PublicationID=20793. Accessed 2013 Jul 2.
22. Gosoniu L, Msengwa A, Lengeler C, Vounatsou P, (2012) Spatially explicit burden estimates of malaria in Tanzania: bayesian geostatistical modeling of the malaria indicator survey data. PLoS ONE 2012 7(5): e23966.
23. Ministry of Planning, Economy and Empowerment (2006) National Population Policy. Dar es Salaam, Tanzania.
24. Yadav P, Cohen J, Alphs S, Arkedis J, Larson PS, et al. (2012) Trends in availability and prices of subsidized act over the first year of the AMFm: evidence from remote regions in Tanzania. Malaria Journal 11: 299.
25. Filmer D, Pritchett LH, (2001) Estimating wealth effects without expenditure data-or tears: an application to educational enrollments in states of India. Demography 38: 115-132.
26. Yamey G, Schaferhoff M, Montagu D, (2012) Piloting the Affordable Medicines Facility-malaria: what will success look like? Bulletin of the WHO 90: 452-460.
27. Fink G, Dickens WT, Jordan M and Cohen JL (2013) Access to Subsidized ACT and malaria treatment-evidence from the first year of the AMFm program in six districts in Uganda. Health Policy and Planning; doi: 10.1093/heapol/czt041.
28. Cohen J, Dupas P, Schaner S (2012) Price subsidies, diagnostic tests and targeting of malaria treatment: evidence from a randomized controlled trial. National Bureau of Economic Research, Working Paper #17943. Available: http://www.nber.org/papers/w17943. Accessed 2013 Jul 2.
29. Kangwana BP, Kedenge SV, Noor AM, Alegana VA, Nyandigisi AJ, et al. (2011) The Impact of Retail-Sector Delivery of Artemether-Lumefantrine on Malaria Treatment of Children under Five in Kenya: A Cluster Randomized Controlled Trial. PLoS Medicine 8(5): e1000437.
30. Sabot OJ, Mwita A, Cohen JM Ipuge Y, Gordon M, et al. (2009) Piloting the global subsidy: the impact of subsidized artemisinin-based combination therapies distributed through private drug shops in rural Tanzania. PLoS One 4: e6857.
31. Halliday KE, Karanja P, Turner EL (2012) Plasmodium falciparum, anaemia and cognitive and educational performance among school children in an area of moderate malaria transmission: baseline results of a cluster randomized trial on the coast of Kenya. Tropical Medicine and International Health 17(5): p.532.
32. Fink G, Olgiati A, Hawela M, Miller JM, Matafwali B, (2013) Association between early childhood exposure to malaria and children's pre-school development: evidence from the Zambia early childhood development project. Malaria Journal 12: 12.
33. Chima R.I., Goodman CA, Mills A (2003) The economic impact of malaria in Africa: a critical review of the evidence. Health Policy. 63(1): p.17-36.
34. Asenso-Okyere K., Asanta FA, Tarekegn J, Andam KS (2011) A review of the economic impact of malaria in agricultural development. Agricultural Economics. 42(3): p.293-304.
35. Goodman CA, Coleman P, Mills A (2000) Economic analysis of malaria control in sub-Saharan Africa. Global forum for health research: promoting research to improve the health of the poor. Geneva, Switzerland.
36. Gallup JL, Sachs JD (2001) The Economic Burden of Malaria. American Journal of Tropical Medicine and Hygiene. 64(1-2 Suppl): 85-96.
37. Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, et al. (2012) Global malaria mortality between 1980 and 2010: a systematic analysis. The Lancet 379: 413-431.
38. Noor AM, Kirui VC, Brooker SJ, Snow RW (2009) The use of insecticide treated nets by age: implications for universal coverage in Africa. BMC Public Health. 9: p.369.
39. Mawili-Mboumba DP, Akotet MKB, Kendjo E, Nzamba J, Medang MO, et al. (2013) Increase in malaria prevalence and age of at risk population in different areas of Gabon. Malaria Journal 12: 3.
40. Cook AG (2006) Forecasting for the Pharmaceutical Industry: Models for New Product and In-Market Forecasting and How to Use Them. Aldershot, England: Gower Publishing.
41. Rogers EM (1962) Diffusion of Innovations. New York: The Free Press.